Bcl-2 homologue Debcl enhances α-synuclein-induced phenotypes in Drosophila.
BACKGROUND
Parkinson disease (PD) is a debilitating movement disorder that afflicts 1-2% of the population over 50 years of age. The common hallmark for both sporadic and familial forms of PD is mitochondrial dysfunction. Mammals have at least twenty proapoptotic and antiapoptotic Bcl-2 family members, in contrast, only two Bcl-2 family genes have been identified in Drosophila melanogaster, the proapoptotic mitochondrial localized Debcl and the antiapoptotic Buffy. The expression of the human transgene α-synuclein, a gene that is strongly associated with inherited forms of PD, in dopaminergic neurons (DA) of Drosophila, results in loss of neurons and locomotor dysfunction to model PD in flies. The altered expression of Debcl in the DA neurons and neuron-rich eye and along with the expression of α-synuclein offers an opportunity to highlight the role of Debcl in mitochondrial-dependent neuronal degeneration and death.


RESULTS
The directed overexpression of Debcl using the Ddc-Gal4 transgene in the DA of Drosophila resulted in flies with severely decreased survival and a premature age-dependent loss in climbing ability. The inhibition of Debcl resulted in enhanced survival and improved climbing ability whereas the overexpression of Debcl in the α-synuclein-induced Drosophila model of PD resulted in more severe phenotypes. In addition, the co-expression of Debcl along with Buffy partially counteracts the Debcl-induced phenotypes, to improve the lifespan and the associated loss of locomotor ability observed. In complementary experiments, the overexpression of Debcl along with the expression of α-synuclein in the eye, enhanced the eye ablation that results from the overexpression of Debcl. The co-expression of Buffy along with Debcl overexpression results in the rescue of the moderate developmental eye defects. The co-expression of Buffy along with inhibition of Debcl partially restores the eye to a roughened eye phenotype.


CONCLUSIONS
The overexpression of Debcl in DA neurons produces flies with shortened lifespan and impaired locomotor ability, phenotypes that are strongly associated with models of PD in Drosophila. The co-expression of Debcl along with α-synuclein enhanced the PD-like phenotypes. The co-expression of Debcl along with Buffy suppresses these phenotypes. Complementary experiments in the Drosophila eye show similar trends during development. Taken all together these results suggest a role for Debcl in neurodegenerative disorders.
Department of Biology, Memorial University of Newfoundland , St. John's, Newfoundland and Labrador , Canada.
P Githure
0000-0002-5044-6196
PG
M'Angale
Department of Biology, Memorial University of Newfoundland , St. John's, Newfoundland and Labrador , Canada.
Brian E
BE
Staveley
Alpha-synuclein; Buffy; Debcl; Drosophila melanogaster; Model of Parkinson disease
Curr Biol. 2000 May 4;10(9):547-50
10801447
Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai). 2002 Jul;34(4):389-94
12098757
J Biol Chem. 2000 Sep 1;275(35):27303-6
10811653
Cold Spring Harb Perspect Med. 2012 Nov 01;2(11):null
23024178
Nucleic Acids Res. 2010 Jul;38(Web Server issue):W695-9
20439314
Mol Syst Biol. 2011 Oct 11;7:539
21988835
F1000Prime Rep. 2015 Apr 01;7:42
26097715
Development. 1993 Jun;118(2):401-15
8223268
Parkinsonism Relat Disord. 2007;13 Suppl 3:S306-8
18267255
EMBO J. 2005 Jul 20;24(14):2700-13
16001086
Biochim Biophys Acta. 2016 Apr;1862(4):518-25
26769358
Mol Cell Neurosci. 2015 May;66(Pt A):29-36
25724482
BMC Neurosci. 2004 Apr 16;5:14
15090075
Dev Cell. 2011 Jul 19;21(1):92-101
21763611
FEBS J. 2015 Mar;282(6):1006-16
25565426
J Biol Chem. 2011 Mar 25;286(12 ):10814-24
21252228
Aging Cell. 2015 Jun;14(3):293-308
25677794
Cell Death Differ. 2007 May;14(5):907-15
17205077
EMBO J. 2003 Jul 15;22(14):3568-79
12853472
Apoptosis. 2014 Oct;19(10 ):1444-56
25208640
Adv Genet. 2011;73:1-50
21310293
Genome. 1990 Dec;33(6):867-72
1964925
Science. 2002 Feb 1;295(5556):865-8
11823645
Nucleic Acids Res. 2015 Jan;43(Database issue):D222-6
25414356
Br J Cancer. 2015 Mar 17;112(6):957-62
25742467
Development. 2009 Jan;136(2):275-83
19088092
Neurobiol Dis. 2010 Oct;40(1):29-39
20561920
Int J Biochem Cell Biol. 2011 May;43(5):732-41
21310263
PLoS One. 2015 Sep 11;10(9):e0137432
26361355
J Biol Chem. 2003 Jul 4;278(27):25009-13
12719433
J Cell Biol. 2008 Sep 22;182(6):1127-39
18794330
Gene. 2013 May 15;520(2):106-18
23470843
Science. 1997 Jun 27;276(5321):2045-7
9197268
Nat Methods. 2012 Jul;9(7):671-5
22930834
BMC Neurosci. 2016 May 18;17(1):24
27192974
Cell Cycle. 2014;13(24):3903-8
25483063
J Immunol Methods. 2002 Jul 1;265(1-2):21-38
12072176
Science. 2000 Jun 16;288(5473):2013-8
10856208
Cell Death Differ. 2015 Jul;22(7):1071-80
25952548
Proc Natl Acad Sci U S A. 2000 Jan 18;97(2):662-7
10639136
Biosci Rep. 2002 Feb;22(1):47-58
12418550
Cell Death Dis. 2014 Sep 04;5:e1405
25188515
Front Biosci (Landmark Ed). 2009 Jan 01;14:4127-37
19273339
Expert Rev Mol Med. 2009 Jul 27;11:e22
19631006
Genetics. 2015 Nov;201(3):843-52
26320097
Arch Toxicol. 2015 Mar;89(3):289-317
25618543
J Cell Sci. 2005 May 1;118(Pt 9):1779-87
15860727
Ann Neurol. 2008 Dec;64 Suppl 2:S3-15
19127586
J Cell Sci. 2015 Sep 1;128(17):3239-49
26208635
Eur J Neurosci. 2007 Dec;26(11):3104-12
18005066
Parkinsons Dis. 2011 Jan 16;2011:693761
21318163
Genesis. 2007 Apr;45(4):184-93
17417787
Genes Dev. 2008 Jun 15;22(12):1577-90
18559474
Nature. 1998 Oct 1 ;395(6701):451-2
9774100
Nucleic Acids Res. 2016 Jan 4;44(D1):D294-300
26615199
Nat Rev Cancer. 2002 Sep;2(9):647-56
12209154
Nature. 2000 Mar 23;404(6776):394-8
10746727
Neurosci Lett. 2010 Dec 17;486(3):235-9
20887775
FEBS J. 2015 Dec;282(24):4727-46
26411401
Curr Biol. 2000 Feb 24;10(4):211-4
10704417
Neuromolecular Med. 2009;11(4):268-80
19855946
Genet Mol Res. 2003 Mar 31;2(1):43-7
12917801
Genes Cancer. 2015 May;6(5-6):241-53
26124923
Cell. 1996 Nov 15;87(4):651-60
8929534
J Cell Biol. 2000 Feb 21;148(4):703-14
10684252
J Neuropathol Exp Neurol. 1996 Mar;55(3):259-72
8786384
Prog Neurobiol. 2013 Jul-Aug;106-107:17-32
23643800
Science. 1998 Aug 28;281(5381):1322-6
9735050